Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Burris

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
American Journal of Physiology. Cell Physiology|January 9, 2026
STL1267 Inhibits Myofibroblast Differentiation in a TGFβ1-Driven Human Lung Fibroblast ModelChandrashekhar Prasad, Steven K Huang, Thomas P Burris, et al.
Plos One|April 18, 2012
Regulation of p53 stability and apoptosis by a ROR agonistYongjun Wang, Laura A Solt, Douglas J Kojetin, et al.
Molecular Genetics and Metabolism|June 11, 2005
Reconstitution of functional nuclear receptor proteins using high pressure refoldingBrigitte E Schoner, Kelli S Bramlett, Haihong Guo, et al.
Biochemical Pharmacology|January 23, 2018
REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009Ariadna Amador, Theodore M Kamenecka, Laura A Solt, et al.
Acta Pharmacologica Sinica|February 26, 2022
The role of REV-ERB in NASHKristine Griffett, Matthew E Hayes, Michael P Boeckman, et al.
Journal of Molecular Graphics & Modelling|August 23, 2003
Molecular determinants of LXRalpha agonismMinmin Wang, Jeffrey Thomas, Thomas P Burris, et al.
Biochimica Et Biophysica Acta|March 10, 2010
A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol)Yongjun Wang, Naresh Kumar, Christine Crumbley, et al.
Biochemical and Biophysical Research Communications|February 22, 2005
Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptorRajesh S Savkur, Kelli S Bramlett, Laura F Michael, et al.
Endocrine-Related Cancer|August 30, 2008
Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptorDouglas J Kojetin, Thomas P Burris, Elwood V Jensen, et al.
Endocrinology|January 7, 2015
ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetesLaura A Solt, Subhashis Banerjee, Sean Campbell, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
American Journal of Physiology. Cell Physiology|January 9, 2026
STL1267 Inhibits Myofibroblast Differentiation in a TGFβ1-Driven Human Lung Fibroblast ModelChandrashekhar Prasad, Steven K Huang, Thomas P Burris, et al.
Plos One|April 18, 2012
Regulation of p53 stability and apoptosis by a ROR agonistYongjun Wang, Laura A Solt, Douglas J Kojetin, et al.
Molecular Genetics and Metabolism|June 11, 2005
Reconstitution of functional nuclear receptor proteins using high pressure refoldingBrigitte E Schoner, Kelli S Bramlett, Haihong Guo, et al.
Biochemical Pharmacology|January 23, 2018
REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009Ariadna Amador, Theodore M Kamenecka, Laura A Solt, et al.
Acta Pharmacologica Sinica|February 26, 2022
The role of REV-ERB in NASHKristine Griffett, Matthew E Hayes, Michael P Boeckman, et al.
Journal of Molecular Graphics & Modelling|August 23, 2003
Molecular determinants of LXRalpha agonismMinmin Wang, Jeffrey Thomas, Thomas P Burris, et al.
Biochimica Et Biophysica Acta|March 10, 2010
A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol)Yongjun Wang, Naresh Kumar, Christine Crumbley, et al.
Biochemical and Biophysical Research Communications|February 22, 2005
Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptorRajesh S Savkur, Kelli S Bramlett, Laura F Michael, et al.
Endocrine-Related Cancer|August 30, 2008
Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptorDouglas J Kojetin, Thomas P Burris, Elwood V Jensen, et al.
Endocrinology|January 7, 2015
ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetesLaura A Solt, Subhashis Banerjee, Sean Campbell, et al.
Pageof 17